Evidence map›Paper›PMID 22609986›Full record

ArticleNature cell biology2012

PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12.

Xiaoqing Gan, Jiyong Wang, Chen Wang, Eeva Sommer, Tohru Kozasa, Srinivasa Srinivasula, Dario Alessi, Stefan Offermanns, Melvin I Simon, Dianqing Wu

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 1 synthesis or guideline pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neutrophil diversity and function in health and disease.Signal transduction and targeted therapy · 2024
    Review
  11. Article
  12. GRespiratory research · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. UsingCells · 2023
    Review
  18. Review
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Xiaoqing GanDepartment of Pharmacology and Program in Vascular Biology and Therapeutics, Yale School of Medicine, New Haven, Connecticut 06520, USA.
Jiyong Wang
Chen Wang
Eeva Sommer
Tohru Kozasa
Srinivasa Srinivasula
Dario Alessi
Stefan Offermanns
Melvin I Simon
Dianqing Wu
Yale University · USUniversity of Dundee · GBMax Planck Society · DENational Institutes of Health · USThe University of Tokyo · JPUniversity of California, San Diego · US

Funding

Vascular Pathophysiology and History Core (VPHC)P01HL070694 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COWAN, ANN E. · 2002 to 2013
$17.5M
Regulation of Rho family GTPases by heterotrimeric G proteinsR01GM061454 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KOZASA, TOHRU, KREUTZ, BARRY S. · 1999 to 2014
$3.3M
Signaling Mechanisms for Leukocyte Migration RegulationR01HL108430 · NHLBI · YALE UNIVERSITY · PI WU, DIANQING · 2011 to 2016
$2.4M
Molecular Function of Chemoattractant-Mediated SignalingR01HL080706 · NHLBI · YALE UNIVERSITY · PI WU, DIANQING · 2005 to 2009
$2.3M
Wnt signalingR01CA139395 · NCI · YALE UNIVERSITY · PI WU, DIANQING · 2009 to 2013
$1.9M
Sustained signaling for fibroblast migrationR01HL120465 · NHLBI · YALE UNIVERSITY · PI WU, DIANQING · 2013 to 2016
$1.6M
Regulation of G Protein Signaling by RGS ProteinsR01GM074001 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KOZASA, TOHRU · 2008 to 2011
$1.2M
Molecular Function of Chemoattractant-Mediated SignalingR01GM054597 · NIGMS · UNIVERSITY OF ROCHESTER · PI WU, DIANQING · 1996 to 2004
$1.2M
Medical Research Council MC_U127015387Medical Research Council MC_U127070193NCI NIH HHS CA139395NCI NIH HHS R01 CA139395NHLBI NIH HHS HL070694NHLBI NIH HHS HL080706NHLBI NIH HHS P01 HL070694NHLBI NIH HHS R01 HL080706NHLBI NIH HHS R01 HL108430NHLBI NIH HHS R01 HL120465NIGMS NIH HHS GM074001NIGMS NIH HHS GM61454NIGMS NIH HHS R01 GM054597NIGMS NIH HHS R01 GM061454NIGMS NIH HHS R01 GM074001
6 · The paper itself

Abstract

Mammalian target of rapamycin complex 2 (mTORC2) phosphorylates AGC protein kinases including protein kinase C (PKC) and regulates cellular functions such as cell migration. However, its regulation remains poorly understood. Here we show that lysophosphatidic acid (LPA) induces two phases of PKC-δ hydrophobic motif phosphorylation. The late phase is mediated by Gα(12), which specifically activates ARAF, leading to upregulation of the RFFL E3 ubiquitin ligase and subsequent ubiquitylation and degradation of the PRR5L subunit of mTORC2. Destabilization of PRR5L, a suppressor of mTORC2-mediated hydrophobic motif phosphorylation of PKC-δ, but not AKT, results in PKC-δ hydrophobic motif phosphorylation and activation. This Gα(12)-mediated signalling pathway for mTORC2 regulation is critically important for fibroblast migration and pulmonary fibrosis development.

Indexed as

Amino Acid MotifsAnimalsApoptosis Regulatory ProteinsBleomycinCell MovementDisease Models, AnimalEnzyme ActivationEnzyme StabilityExtracellular Signal-Regulated MAP KinasesFibroblastsGTP-Binding Protein alpha Subunits, G12-G13HEK293 CellsHumansIntracellular Signaling Peptides and ProteinsLungLysophospholipidsApoptosis Regulatory ProteinsBleomycinExtracellular Signal-Regulated MAP KinasesGTP-Binding Protein alpha Subunits, G12-G13Intracellular Signaling Peptides and Proteinslysophosphatidic acidLysophospholipidsMechanistic Target of Rapamycin Complex 2Multiprotein ComplexesPrkcd protein, mouseProtein Kinase C-deltaProteinsProto-Oncogene Proteins c-aktprotor-2 protein, mouseRffl protein, mouseTOR Serine-Threonine KinasesTrans-ActivatorsUbiquitin-Protein Ligases

Identifiers

PMID22609986
PMCPMC3389271
OpenAlexW1496824237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.